Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

40.45
-0.5450-1.33%
Volume:4K
Turnover:176.47K
Market Cap:201.42M
PE:- -
High:41.07
Open:41.00
Low:40.43
Close:40.99
52wk High:47.00
52wk Low:29.28
Shares:4.98M
Float Shares:4.98M
Volume Ratio:0.56
T/O Rate:0.09%
Dividend:0.02
Dividend Rate:0.05%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly Gets FDA OK for Onswik Once-Weekly Insulin Injection

Dow Jones
·
Sep 24

Eli Lilly - Onswik Kwikpen to be Available in U.S. in 500 Units/Ml and 1,000 Units/Ml Concentrations

THOMSON REUTERS
·
Sep 24

U.S. Food and Drug Administration (FDA) Approves Lilly's Onswik™ (Insulin Efsitora Alfa-Gobe), a Once-Weekly Basal Insulin Injection Treatment for Adults Living with Type 2 Diabetes

THOMSON REUTERS
·
Sep 24

Revolution Medicines (RVMD) Gets a Buy from Goldman Sachs

TIPRANKS
·
Sep 24

Legend Biotech CFO Makes a Notable Move With Fresh Insider Stock Sale

TIPRANKS
·
Sep 24

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 24

Eli Lilly & Co. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 24

Roche to Move Quickly Toward Filing for Approval of New Autoimmune Drug

Dow Jones
·
Sep 23

Roche is Becoming More Productive

Dow Jones
·
Sep 23

Roche’s Genentech reports ‘positive’ results from Phase 3 Imagination study

TIPRANKS
·
Sep 23

Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT

Reuters
·
Sep 23

Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000

Reuters
·
Sep 23

Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial

Dow Jones
·
Sep 22

Eli Lilly Price Target Maintained with a $1250.00/Share by TD Cowen

Dow Jones
·
Sep 22

European Pharma Leaders Push for National Reforms to Boost Investment

Dow Jones
·
Sep 22

Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire

Dow Jones
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 22

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Reuters
·
Sep 22

AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib

GlobeNewswire
·
Sep 22

Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015

GlobeNewswire
·
Sep 22